The Chile Fund, Inc. Announces Performance Data and Portfolio Composition
|
| Posted
:
Mon, 02 Nov 2009 17:25:25 GMT |
| Author
:
The Chile Fund, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
PHILADELPHIA, Nov. 2 PA-Chile-Fund-data
PHILADELPHIA, Nov. 2 /PRNewswire-FirstCall/ -- The Chile Fund, Inc. (the "Fund") (NYSE AMEX: CH), a closed-end equity fund, announced today its performance data and portfolio composition as of September 30, 2009.
The Fund's total returns for various periods through September 30, 2009 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
Period NAV Total Return % Market Price Total Return %
Cumulative Annualized Cumulative Annualized
Since inception 1,569.5 15.1 1,382.3 14.4
(September 1989)
10-years 214.5 12.1 303.4 15.0
5-years 112.0 16.2 122.4 17.3
3-years 46.6 13.6 34.9 10.5
1-year 14.1 33.8
On September 30, 2009, the Fund's net assets amounted to US$171.3 million and the Fund's NAV per share was $16.85.
As of September 30, 2009, the portfolio was invested as follows:
Portfolio Composition Percent of
Net Assets
Utilities 32.3
Basic Materials 18.1
Diversified 16.9
Consumer, Non-Cyclical 9.9
Consumer, Cyclical 8.5
Financials 7.7
Communications 3.9
Other 2.7
The Fund's ten largest equity holdings as of September 30, 2009, representing 77.8% of net assets, were:
Stock Percent of
Net Assets
Empresa Nacional de Electricidad SA 16.9
Empresas Copec SA 16.9
Empresas CMPC SA 8.8
Enersis SA 7.1
Banco Santander Chile SA 6.4
SACI Falabella 5.0
Inversiones Aquas Metropolitanas SA 4.5
Vina de Concha y Toro SA 4.4
Colbun SA 3.9
Entel Empresa de Telecommunicaciones 3.9
Important Information
Aberdeen Asset Management Inc. has prepared this report based on information sources believed to be accurate and reliable. However, the figures are unaudited and neither the Fund, Aberdeen Asset Management Investment Services Limited (the Investment Adviser), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information. Aberdeen is a U.S. registered service mark of Aberdeen Asset Management PLC.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date September 27, 1989.
If you wish to receive this information electronically, please contact: InvestorRelations@aberdeen-asset.com
SOURCE The Chile Fund, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Reportlinker Adds Veterinary Vaccines - A World Market Analysis
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Merge Healthcare and InSite One Expand License Agreement to Include New Solution MILWAUKEE -
Merge Healthcare (NASDAQ:MRGE),
announced today that InSite One, a le
JohnsonDiversey and JohnsonDiversey Holdings Announce Results of Tender Offers and Early Acceptance of Notes in Tender Offers for 9.625% Senior Subordinated Notes Due 2012 and 10.67% Senior Discount Notes Due 2013 STURTEVANT, Wis. -
JohnsonDiversey, Inc. (“JohnsonDiversey”) and JohnsonDiversey Holdings,
Inc. (“JohnsonDiversey Holdings”) announced today the early acceptance
of tendered notes in connection with JohnsonDiversey’s previously
announced cash tender offers for i
BreitBurn Energy Partners Responds to Inaccurate Press Release Issued by Quicksilver Resources LOS ANGELES -
On October 31, 2008, Fort Worth, Texas-based Quicksilver Resources Inc.,
a limited partner in BreitBurn Energy Partners L.P. (“BreitBurn” or the
“partnership”), filed a lawsuit in Fort Worth against BreitBurn.
BreitBurn believes that this lawsuit is part
Reportlinker Adds Cancer Therapies - Global Market Opportunities
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement CAMBRIDGE, Mass. -
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that
Novartis will terminate its research collaboration agreement with the
Company, effective as of February 21, 2010.
“We appreciate the commitment Novartis scientists provided throughout
Lithium-Ion Battery Maker EnerDel Enters Utility Energy Storage Market, Will Supply New DOE-Backed Smart Grid Program
INDIANAPOLIS, Nov. 25 -- Advanced lithium-ion battery maker EnerDel will enter the utility-scale energy storage market, supplying batteries for a major new smart grid program announced yesterday by the US Department of Energy. EnerDel will build the batter...
|
|
|
|
|
|
|
|
|